278 results on '"CORNELLI, Umberto"'
Search Results
2. Pycnogenol® supplementation to relieve symptoms after hemorrhoidectomy
3. Pycnogenol® prevents skin hyperpigmentation following sclerotherapy
4. Pycnogenol® improves cognitive function in post-stroke patients: a 6 month-study
5. Correction to: Intestinal fat absorption shifting: polyglucosamine biopolymer controls lipids and weight and reduces the progression of subclinical atherosclerosis
6. Parkinson's Disease and Food Expenditure in Italy: Stochastic and Non-Stochastic Analyses
7. Prevention and control of jet lag symptoms and temporary impairment of cognitive function with Pycnogenol® in healthy individuals and in hypertensives
8. Humoral Factors in the Skin
9. Intestinal fat absorption shifting by polyglucosamine biopolymer: control of lipids and reduction of progression of early subclinical atherosclerosis
10. Long-Term Treatment of Overweight and Obesity with Polyglucosamine (PG L112): Randomized Study Compared with Placebo in Subjects after Caloric Restriction
11. Positive effects of Pycnogenol®-Centellicum® on venous elasticity: an ex-vivo concept study
12. Intestinal fat absorption shifting by polyglucosamine biopolymer: control of lipids and reduction of progression of early subclinical atherosclerosis.
13. Borderline hyperlipidemia preventive management with Berberine PL in asymptomatic prevention of early atherosclerosis.
14. Pycnogenol® improves cognitive function in post-stroke patients: a 6 month-study.
15. Effects of Pycnogenol® in women with postmenopausal symptoms: a 90-day comparative study
16. Efficacy of the combination Pycnogenol® and Centellicum® on preventing the progression of atherosclerotic plaques: a morphological study
17. Intestinal fat absorption shifting: polyglucosamine biopolymer controls lipids and weight and reduces the progression of subclinical atherosclerosis
18. Correlation between Foods Expenditure and Breast Cancer in Italy
19. Glycosaminoglycans and Analogs in Neurodegenerative Disorders
20. Prospective Role of Glycosaminoglycans in Apoptosis Associated with Neurodegenerative Disorders
21. Chronic venous insufficiency and microangiopathy: supplementation with Pycnogenol® reduces the progression of venous disease in women
22. A standard model for venous thrombosis. A quantum view
23. Glycosaminoglycans as Potential Future Treatment of Alzheimer’s Disease
24. Glycosaminoglycans and Glycomimetics: Potential Role in the Management of Alzheimer’s Disease
25. C3, A Promising Ultra Low Molecular Weight Glycosaminoglycan for the Treatment of Alzheimer’s Disease
26. Robuvit® reduces fatigue after chemotherapy for colon cancer. A pilot registry study.
27. Prevention of work-related stress, fatigue, loss of cognitive function, improved attention and recovery of stamina with Robuvit® in professionals with increased oxidative stress
28. Humoral Factors in the Skin
29. Non-Anticoagulant Actions of Glycosaminoglycans (GAGs) : The Therapeutical Approach to Alzheimer’s Disease
30. Preventive effects of Pycnogenol® on cardiovascular risk factors (including endothelial function) and microcirculation in subjects recovering from coronavirus disease 2019 (COVID-19)
31. Effects of Pycnogenol® in women with postmenopausal symptoms: a 90-day comparative study.
32. Pycnogenol®-Centellicum® supplementation improves lung fibrosis and post-COVID-19 lung healing
33. Intestinal fat absorption shifting (IFAS) with a chitosan biopolymer slows down the progression of subclinical atherosclerosis. A pilot study
34. Chronic venous insufficiency (CVI) in diabetics: supplementation with Pycnogenol®+Centellicum® prevents edema and the evolution of microangiopathy.
35. Determining the Prostate Cancer Road Map Hypothesis in 49 Countries: From Iron-Deficiency Anemia (IDA) to Death
36. The Efficacy of Sulodexide in the Prevention of Postthrombotic Syndrome
37. The Carotid Intima-Media Thickness Modification Following Atorvastatin is Bound to the Modification of the Oxidative Balance
38. Diabetes Type II and Covid-19: Need of Rethinking
39. Analysis of COVID -19: Where Do We Stand?
40. The COVID-19 History in Italy: Correlations with Environment, Demographic Variables and Chronic Diseases Therapy
41. Covid-19 Aging and Chronic Diseases
42. The COVID-19 Infection in Lombardia comes from China
43. Cov19 in Italy: Correlation with Clinical, Demographical, Social Variables, and Water
44. Supplementary Management with Pycnogenol®-Centellicum® may Slow Down the Progression of Pulmonary Fibrosis and Improve Post-COVID-19 Lung Healing
45. Breast Cancer Analysis in 49 Countries in Relation to Iron Deficiency Anemia (IDA), Chlamydia and HIV Infections
46. Determination of Plasma Antioxidant Power in Capillary Blood through the Innovative system PAT (Plasma Antioxidant Test)
47. Molecular weight dependent tissue factor pathway inhibitor release by heparin and heparin oligosaccharides
48. Activity of two different polyglucosamines, L112® and FF45®, on body weight in male rats
49. The Effect of COVID-19 Vaccinations in 47 European Countries
50. COVID-19 Pandemic: Lethal and Non-lethal Drifts
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.